57
Participants
Start Date
May 3, 2016
Primary Completion Date
October 13, 2016
Study Completion Date
October 13, 2016
Use of digital disease management tool in participants with T2DM
The purpose of this study is to evaluate if the provision of a digital disease management tool in addition to standard care for T2DM, will improve glycaemic control. The impact of the tool will be assessed in comparison to a Control group who will receive standard care alone. All participants will complete the PRO assessments. This is a real-world study carried out at the point of care intended to assist health care practitioners and managed care providers to make evidence-based decisions about how to improve participant self-management of their diabetes.
Research Site, Dundee
Research Site, Cardiff
Research Site, Muirhead
Research Site, Flintshire
Research Site, London
Research Site, Manchester
Research Site, Oldham
Research Site, Mid Glamorgan
Research Site, Bonnyrigg
Research Site, Edinburgh
Research Site, Fife
Research Site, Leicester
Research Site, London
Research Site, Stockport
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY